Jane C Bell1, Gareth Baynam2,3, Jorieke E H Bergman4, Eva Bermejo-Sánchez5, Lorenzo D Botto6,7, Mark A Canfield8, Saeed Dastgiri9, Miriam Gatt10, Boris Groisman11, Paula Hurtado-Villa12, Karin Kallen13, Babak Khoshnood14, Victoria Konrad15,16, Danielle Landau17, Jorge S Lopez-Camelo18, Laura Martinez19, Margery Morgan20, Osvaldo M Mutchinick21, Amy E Nance22, Wendy Nembhard23, Anna Pierini24, Anke Rissmann25, Xiaoyi Shan26, Antonin Sipek27, Elena Szabova28, Giovanna Tagliabue29, Lyubov S Yevtushok30,31, Ignacio Zarante32, Natasha Nassar1. 1. Child Population and Translational Health Research, Children's Hospital at Westmead Clinical School, University of Sydney, Sydney, Australia. 2. The Western Australian Register of Developmental Anomalies, Department of Health, Government of Western Australia, Subiaco, Australia. 3. School of Medicine, Division of Pediatrics; and Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia. 4. University of Groningen, University Medical Center Groningen, Department of Genetics, Groningen, The Netherlands. 5. ECEMC, Research Unit on Congenital Anomalies, Institute of Rare Diseases Research (IIER), Instituto de Salud Carlos III, Madrid, Spain. 6. International Center on Birth Defects (ICBD) of the International Clearinghouse for Birth Defects Surveillance and Research (ICBDSR), Division of Medical Genetics, University of Utah School of Medicine, Salt Lake City, Utah, USA. 7. Division of Medical Genetics, Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, Utah, USA. 8. Birth Defects Epidemiology and Surveillance Branch, Texas Department of State Health Services, Austin, Texas, USA. 9. Tabriz Health Services Management Research Center, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran. 10. Malta Congenital Anomalies Registry, Directorate for Health Information and Research, Guardamangia, Malta. 11. National Network of Congenital Anomalies of Argentina (RENAC), National Center of Medical Genetics, National Administration of Laboratories and Health Institutes (ANLIS), National Ministry of Health, Buenos Aires, Argentina. 12. Pontificia Universidad Javeriana Cali, Centro Médico Imbanaco, Cali, Colombia. 13. Swedish National Board of Health and Welfare and Institution of Clinical Sciences, Lund, University of Lund, Stockholm, Sweden. 14. Université de Paris, Center of Research in Epidemiology and Statistics/CRESS/Obstetrical Perinatal and Pediatric Epidemiology Research Team (EPOPé), INSERM, INRA, Paris, France. 15. National Center on Birth Defects and Developmental Disabilities, US Centers for Disease Control and Prevention, Atlanta, Georgia, USA. 16. National Center on Birth Defects and Developmental Disabilities, Carter Consulting, Incorporated, Atlanta, Georgia, USA. 17. Department of Obstetrics and Gynecology, Soroka University Medical Center, Beersheva, Israel. 18. ECLAMC, Latin American Collaborative Study of Congenital Malformations, Buenos Aires, Argentina. 19. Registro DAN (Registro de Defectos al Nacimiento), Departamento de Genética, Hospital Universitario Dr. José E. González. Universidad Autónoma de Nuevo León, Monterrey, Mexico. 20. CARIS (Congenital Anomaly Register & Information Services), Public Health Wales, Singleton Hospital, Swansea, UK. 21. RYVMCE, Department of Genetics, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico. 22. Utah Department of Health, Bureau of Children with Special Health Care Needs, Utah Birth Defect Network, Salt Lake City, Utah, USA. 23. Department of Epidemiology and the Arkansas Reproductive Health Monitoring System, University of Arkansas for Medical Sciences, Fay W Boozman College of Medicine, Little Rock, Arkansas, USA. 24. Institute of Clinical Physiology, National Research Council/Fondazione Toscana Gabriele Monasterio, Pisa, Italy. 25. Malformation Monitoring Centre Saxony-Anhalt, Medical Faculty Otto-von-Guericke University Magdeburg, Magdeburg, Germany. 26. Arkansas Children's Hospital, Arkansas Children's Research Institute, Little Rock, Arkansas, USA. 27. Department of Medical Genetics, Thomayer Hospital, Prague, Czech Republic. 28. Slovak Medical University in Bratislava, Faculty of Public Health, Bratislava, Slovak Republic. 29. Cancer Registry Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Lombardy, Italy. 30. OMNI-Net Ukraine Birth Defects Program, Rivne, Ukraine. 31. Rivne Regional Medical Diagnostic Center, Rivne, Ukraine. 32. Instituto de Genética Humana, Pontificia Universidad Javeriana Bogotá, Bogota, Colombia.
Abstract
BACKGROUND: Esophageal atresia (EA) affects around 2.3-2.6 per 10,000 births world-wide. Infants born with this condition require surgical correction soon after birth. Most survival studies of infants with EA are locally or regionally based. We aimed to describe survival across multiple world regions. METHODS: We included infants diagnosed with EA between 1980 and 2015 from 24 birth defects surveillance programs that are members of the International Clearinghouse for Birth Defects Surveillance and Research. We calculated survival as the proportion of liveborn infants alive at 1 month, 1- and 5-years, among all infants with EA, those with isolated EA, those with EA and additional anomalies or EA and a chromosomal anomaly or genetic syndrome. We also investigated trends in survival over the decades, 1980s-2010s. RESULTS: We included 6,466 liveborn infants with EA. Survival was 89.4% (95% CI 88.1-90.5) at 1-month, 84.5% (95% CI 83.0-85.9) at 1-year and 82.7% (95% CI 81.2-84.2) at 5-years. One-month survival for infants with isolated EA (97.1%) was higher than for infants with additional anomalies (89.7%) or infants with chromosomal or genetic syndrome diagnoses (57.3%) with little change at 1- and 5-years. Survival at 1 month improved from the 1980s to the 2010s, by 6.5% for infants with isolated EA and by 21.5% for infants with EA and additional anomalies. CONCLUSIONS: Almost all infants with isolated EA survived to 5 years. Mortality was higher for infants with EA and an additional anomaly, including chromosomal or genetic syndromes. Survival improved from the 1980s, particularly for those with additional anomalies.
BACKGROUND: Esophageal atresia (EA) affects around 2.3-2.6 per 10,000 births world-wide. Infants born with this condition require surgical correction soon after birth. Most survival studies of infants with EA are locally or regionally based. We aimed to describe survival across multiple world regions. METHODS: We included infants diagnosed with EA between 1980 and 2015 from 24 birth defects surveillance programs that are members of the International Clearinghouse for Birth Defects Surveillance and Research. We calculated survival as the proportion of liveborn infants alive at 1 month, 1- and 5-years, among all infants with EA, those with isolated EA, those with EA and additional anomalies or EA and a chromosomal anomaly or genetic syndrome. We also investigated trends in survival over the decades, 1980s-2010s. RESULTS: We included 6,466 liveborn infants with EA. Survival was 89.4% (95% CI 88.1-90.5) at 1-month, 84.5% (95% CI 83.0-85.9) at 1-year and 82.7% (95% CI 81.2-84.2) at 5-years. One-month survival for infants with isolated EA (97.1%) was higher than for infants with additional anomalies (89.7%) or infants with chromosomal or genetic syndrome diagnoses (57.3%) with little change at 1- and 5-years. Survival at 1 month improved from the 1980s to the 2010s, by 6.5% for infants with isolated EA and by 21.5% for infants with EA and additional anomalies. CONCLUSIONS: Almost all infants with isolated EA survived to 5 years. Mortality was higher for infants with EA and an additional anomaly, including chromosomal or genetic syndromes. Survival improved from the 1980s, particularly for those with additional anomalies.
Authors: E Robert; O Mutchinick; P Mastroiacovo; L B Knudsen; A K Daltveit; E E Castilla; P Lancaster; B Källén; G Cocchi Journal: Reprod Toxicol Date: 1993 Sep-Oct Impact factor: 3.143
Authors: Pedro Jose Lopez; Charles Keys; Agostino Pierro; David Paul Drake; Edward Matthew Kiely; Joseph Ignatius Curry; Lewis Spitz Journal: J Pediatr Surg Date: 2006-02 Impact factor: 2.545
Authors: Philip J Lupo; Jennifer L Isenburg; Jason L Salemi; Cara T Mai; Rebecca F Liberman; Mark A Canfield; Glenn Copeland; Sarah Haight; Sanjiv Harpavat; Adrienne T Hoyt; Cynthia A Moore; Wendy N Nembhard; Hoang N Nguyen; Rachel E Rutkowski; Amy Steele; C J Alverson; Erin B Stallings; Russell S Kirby Journal: Birth Defects Res Date: 2017-11-01 Impact factor: 2.344
Authors: D M Burge; K Shah; P Spark; N Shenker; M Pierce; J J Kurinczuk; E S Draper; P R V Johnson; M Knight Journal: Br J Surg Date: 2013-01-18 Impact factor: 6.939
Authors: Débora Gusmão Melo; Maria Teresa Vieira Sanseverino; Thanyse de Oliveira Schmalfuss; Mariela Larrandaburu Journal: Front Public Health Date: 2021-11-02